Arcturus Therapeutics Holdings (ARCT) Asset Utilization Ratio (2019 - 2026)

Arcturus Therapeutics Holdings' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.21 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 50.18% year-over-year to 0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.21 (down 50.18% YoY) and the FY2025 annual result came in at 0.27, down 32.29% from the prior year.
• Asset Utilization Ratio was 0.21 for Q1 2026 at Arcturus Therapeutics Holdings, down from 0.3 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.67 in Q3 2023 and bottomed at 0.04 in Q1 2022.
• A 5-year average of 0.37 and a median of 0.38 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 1753.49% — and 2024, when it plunged 51.88%.
• Arcturus Therapeutics Holdings' Asset Utilization Ratio stood at 0.55 in 2022, then sank by 32.09% to 0.38 in 2023, then climbed by 13.33% to 0.43 in 2024, then plunged by 30.45% to 0.3 in 2025, then declined by 28.54% to 0.21 in 2026.
• Business Quant data shows ARCT's Asset Utilization Ratio at 0.21 in Q1 2026, 0.3 in Q4 2025, and 0.33 in Q3 2025.